✦ LIBER ✦

Acute nonlymphocytic leukemia following chemotherapy with cisplatin and etoposide for non-small-cell carcinoma of the lung: case report

✍ Scribed by Daniel Brenez; Jacques Devriendt; Christine Lenclud; Jacqueline Schmerber

Publisher: Springer
Year: 1990
Tongue: English
Weight: 237 KB
Volume: 26
Category: Article
ISSN: 0344-5704
DOI: 10.1007/bf02897207

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute leukemia following intensive thera

Acute leukemia following intensive therapy for small-cell carcinoma of the lung

✍ Maurie Markman; Michael D. Pavy; Martin D. Abeloff 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 918 KB

Mitomycin C, teniposide, and cisplatin c

Mitomycin C, teniposide, and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung

✍ Giuseppe Giaccone; Valter Iberti; Michaela Donadio; Franco Testore 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 275 KB

Pemertrexed combined with cisplatin in t

Pemertrexed combined with cisplatin in the treatment of advanced non-small cell lung cancer: a case report and literature review

✍ Changlin Zhao; Fangjuan Hu; Ganlu Zhang; Junbo Yuan; Wenjun Zhang 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 313 KB

Combination chemotherapy with adriamycin

Combination chemotherapy with adriamycin, etoposide, and cyclophosphamide for small cell carcinoma of the lung. A study by the EORTC lung cancer working party (Belgium)

✍ J. Klastersky; J. P. Sculier; J. P. Dumont; D. Becquart; G. Vandermoten; P. Rocm 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 425 KB 👁 2 views

The addition of cisplatin to cyclophosph

The addition of cisplatin to cyclophosphamide-doxorubicin-etoposide combination chemotherapy in the treatment of patients with small cell lung carcinoma : A randomized study of 457 patients

✍ Thierry Urban; Claude Chastang; François-Xavier Lebas; Jean-Paul Duhamel; Guy Ad 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 94 KB 👁 2 views

## BACKGROUND. To assess whether the addition of cisplatin (100 mg/m 2 administered intravenously on Day 1) to CDE (cyclophosphamide [1000 mg/m 2 on Day 1], doxorubicin [45 mg/m 2 on Day 1], and etoposide [150 mg/m 2 on Days 1 and 2] combination is useful in the treatment of patients with small cel

Accelerated radiotherapy followed by che

Accelerated radiotherapy followed by chemotherapy for locally recurrent small-cell carcinoma of the lung. A phase II study of cancer and leukemia group B

✍ N.C. Choi; K. Propert; R. Carey; W. Eaton; L.A. Leone; P. Silberfarb; M. Green 📂 Article 📅 1987 🏛 Elsevier Science 🌐 English ⚖ 918 KB